PNC Financial Services Group
TVRD

PNC Financial Services Group’s Tvardi Therapeutics TVRD Stock Holding History

PNC Financial Services Group’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.68K Buy
3,518
+2,999
+578% +$9.4K ﹤0.01% 4281
2026
Q1 		$1.65K Buy
519
+225
+77% +$882 ﹤0.01% 4639
2025
Q4 		$1.26K Buy
294
+246
+513% +$2.21K ﹤0.01% 4639
2025
Q3 		$1.87K Buy
+48
New +$1.37K ﹤0.01% 4514
2024
Q1 		– Sell
-2
Closed -$52 – 4840
2023
Q4 		$52 Buy
+2
New +$83 ﹤0.01% 4561
2023
Q2 		– Sell
-34
Closed -$5.93K – 4852
2023
Q1 		$5.93K Sell
34
-62
-65% -$20.8K ﹤0.01% 3980
2022
Q4 		$36.9K Hold
96
– – ﹤0.01% 3153
2022
Q3 		$32K Buy
96
+23
+32% +$8.33K ﹤0.01% 3219
2022
Q2 		$24K Buy
73
+28
+62% +$9.82K ﹤0.01% 3415
2022
Q1 		$20K Sell
45
-6
-12% -$2.46K ﹤0.01% 3586
2021
Q4 		$23K Sell
51
-41
-45% -$20.6K ﹤0.01% 3492
2021
Q3 		$52K Buy
92
+45
+96% +$22.6K ﹤0.01% 3052
2021
Q2 		$24K Buy
47
+44
+1,467% +$27.9K ﹤0.01% 3399
2021
Q1 		$2K Hold
3
– – ﹤0.01% 3979
2020
Q4 		$1K Sell
3
-5
-63% -$2.62K ﹤0.01% 3924
2020
Q3 		$4K Hold
8
– – ﹤0.01% 3730
2020
Q2 		$5K Hold
8
– – ﹤0.01% 3651
2020
Q1 		$4K Sell
8
-26
-76% -$14.1K ﹤0.01% 3650
2019
Q4 		$20K Hold
34
– – ﹤0.01% 3321
2019
Q3 		$22K Sell
34
-23
-40% -$19.1K ﹤0.01% 3309
2019
Q2 		$44K Buy
57
+7
+14% +$4.92K ﹤0.01% 3004
2019
Q1 		$36K Hold
50
– – ﹤0.01% 3131
2018
Q4 		$23K Hold
50
– – ﹤0.01% 3251
2018
Q3 		$43K Sell
50
-22
-31% -$15.9K ﹤0.01% 3088
2018
Q2 		$49K Sell
72
-56
-44% -$28.5K ﹤0.01% 2992
2018
Q1 		$56K Hold
128
– – ﹤0.01% 2902
2017
Q4 		$56K Hold
128
– – ﹤0.01% 2896
2017
Q3 		$64K Hold
128
– – ﹤0.01% 2793
2017
Q2 		$70K Buy
128
+28
+28% +$17.8K ﹤0.01% 2725
2017
Q1 		$66K Buy
100
+93
+1,329% +$49.7K ﹤0.01% 2754
2016
Q4 		$2K Buy
+7
New +$2.25K ﹤0.01% 3867

Other funds holding TVRD

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AFG
American Financial Group Cincinnati, Ohio $284M AUM 12.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DWAM
Duncan Williams Asset Management Memphis, Tennessee $444M AUM 24.78% 1-Year Est. Return

PNC Financial Services Group's TVRD Position: Q2 2026 in Review

PNC Financial Services Group increased its Tvardi Therapeutics (TVRD) stake by 578% in Q2 2026, buying an estimated $9.4K and bringing the position to 3,518 shares worth $6.68K. The position accounts for ﹤0.01% of the portfolio, ranked #4281.

PNC Financial Services Group first reported a position in TVRD in Q4 2016 and has held it in 31 quarters since. The position peaked at $70K in Q2 2017. 58 funds tracked by Wall St. Rank hold TVRD as of Q2 2026.

  • PNC Financial Services Group held 3,518 shares of Tvardi Therapeutics worth $6.68K as of Q2 2026.
  • PNC Financial Services Group bought 2,999 Tvardi Therapeutics shares in Q2 2026, an estimated $9.4K.
  • Tvardi Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4281 holding.
  • PNC Financial Services Group first reported a position in Tvardi Therapeutics in Q4 2016 and has held it in 31 quarters since.
  • PNC Financial Services Group's Tvardi Therapeutics position peaked at $70K in Q2 2017.
  • 58 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.